Document is current
Any future updates will be listed below
-
Authors
Juráková, Veronika
Széky, Balázs
Zapletalová, Martina
Fehér, Anita
Zana, Melinda
Pandey, Shashank
Kučera, Radek
Šerý, Omar
Hudeček, Jiří
Dinnyés, András
Lochman, Jan
-
Funding
Funding for this research was provided by:
Ministerstvo Zdravotnictví Ceské Republiky (NU20-09-00437, NU20-09-00437, NU20-09-00437, NU20-09-00437, NU20-09-00437, NU20-09-00437, NU20-09-00437)
Hungarian Grants (2020–1.1.5-GYORSÍTÓSÁV-2021- 00016, 2020–1.1.5-GYORSÍTÓSÁV-2021- 00016, 2020–1.1.5-GYORSÍTÓSÁV-2021- 00016, 2020–1.1.5-GYORSÍTÓSÁV-2021- 00016)
ERA-NET NEURON Research Programme (2019-2.1.7-ERANET-2022-00031, 2019-2.1.7-ERANET-2022-00031, 2019-2.1.7-ERANET-2022-00031, 2019-2.1.7-ERANET-2022-00031)
- License Information
-
More Information
Article History
Received: 28 June 2024
Accepted: 9 September 2024
First Online: 28 September 2024
Declarations
:
: Our research fully adheres to ethical standards and guidelines. The ethical licence was issued by the Scientific and Research Ethics Committee of the Hungarian Health Science Council for “Production of induced pluripotent stem cells (IPS) from human somatic samples” with the following ID No.: IV/3935- 1/2021/EKU in May 2021. The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethical Committee, University Hospital Pilsen and Faculty of Medicine in Pilsen, Charles University, Edvarda Beneše 1128/13, 30599 Pilsen – Czech Republic (email: etickakomise@302 fnplzen.cz) on 19th June 2019.
: Not applicable.
: The authors declare no competing interests.
